// App-Quantinova.ai

: NIVOLUMAB IN COMBINATION WITH BRENTUXIMAB VEDOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA AFTER FAILURE OF NIVOLUMAB MONOTHERAPY

Researchers

Presenter

  • Luibov Tsvetkova

Principal Investigators

  • Kirill Lepik

  • Andrey Kozlov

  • Elena Kondakova

  • Yuriy Zalyalov

  • Evgeniya Borzenkova

  • Vadim Baykov

  • Natalia Mikhailova

  • Boris Afanasyev

Medical Centers

  • RM Gorbacheva Research Institute of Pediatric Oncology, Hematology and Transplantation,St. Petersburg,Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Adcetris

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved